KRUS' fiscal Q2 performance is likely to have gained from unit expansion efforts, operational improvements and technological ...

Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced ...

Blog - For many women in Kura, pregnancy and childbirth remain a dangerous journey. The lack of adequate maternal healthcare ...

Kura Sushi USA, Inc. (NASDAQ:KRUS – Get Free Report) has earned an average rating of “Moderate Buy” from the eleven ...

Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation ...

The chair of a kura kaupapa involved in a crash in South Taranaki in which 11 of its students were injured says the support ...

Kura Oncology (KURA) announced that on April 1, the Compensation Committee of the Company’s Board of Directors granted inducement awards ...

Barclays lowered the firm’s price target on Kura Sushi (KRUS) to $75 from $102 and keeps an Equal Weight rating on the shares as part of a ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

A visit to Ōhiwa Harbour might first be about picturesque views and the rich cultural history but beneath the surface, ...

Kura Revolving Sushi Bar is opening soon in McKinney’s West Grove development, a company representative confirmed.